Track the OncoMed Pharmaceuticals Inc share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 12 January 2016 (Levée d'options). Among the most active insiders: Dupont Jakob. All data is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
21 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
OncoMed Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It specializes in the discovery and development of drugs targeting tumor stem cells.